Results 31 to 40 of about 442,357 (177)

Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers. [PDF]

open access: yesInt J Urol
Kato T., Yajima S., Nakamura Y., et al. Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers. International Journal of Urology (2025); https://doi.org/10.1111/iju.70215.While the clinical outcome for ...
Kato T   +4 more
europepmc   +2 more sources

Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients [version 3; referees: 1 approved, 2 approved with reservations]

open access: yesF1000Research, 2017
Ensemble methods have been successfully applied in a wide range of scenarios, including survival analysis. However, most ensemble models for survival analysis consist of models that all optimize the same loss function and do not fully utilize the ...
Sebastian Pölsterl   +5 more
doaj   +1 more source

Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer [PDF]

open access: yes, 2016
The American Society of Clinical Oncology Genitourinary Cancers Symposium, Moscone West Building, San Francisco, CA, USA, 7-9 January 2016 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco (CA, USA ...
Iacovelli, Roberto   +19 more
core   +2 more sources

Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients [version 2; referees: 1 approved, 2 approved with reservations]

open access: yesF1000Research, 2017
Ensemble methods have been successfully applied in a wide range of scenarios, including survival analysis. However, most ensemble models for survival analysis consist of models that all optimize the same loss function and do not fully utilize the ...
Sebastian Pölsterl   +5 more
doaj   +1 more source

Inside the 2015 ASCO Genitourinary Cancers Symposium

open access: yes, 2015
The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Rosen Shingle Creek, Orlando, FL, USA, 26-28 February 2015 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium was held in Orlando (FL, USA ...
Iacovelli, Roberto   +19 more
core   +2 more sources

SNP-SNP interactions as risk factors for aggressive prostate cancer [version 1; referees: 2 approved]

open access: yesF1000Research, 2017
Prostate cancer (PCa) is one of the most significant male health concerns worldwide. Single nucleotide polymorphisms (SNPs) are becoming increasingly strong candidate biomarkers for identifying susceptibility to PCa.
Venkatesh Vaidyanathan   +6 more
doaj   +1 more source

Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach [version 1; referees: 2 approved, 1 approved with reservations]

open access: yesF1000Research, 2016
In this paper, we present our winning method for survival time prediction in the 2015 Prostate Cancer DREAM Challenge, a recent crowdsourced competition focused on risk and survival time predictions for patients with metastatic castration-resistant ...
Detian Deng   +6 more
doaj   +1 more source

Pathogenesis and Diagnosis of Genitourinary Cancer

open access: yes, 2021
Genitourinary (GU) cancers are among the most common malignant diseases in men [...
Jae Y. Ro   +2 more
core   +1 more source

Mapping of microRNAs related to cervical cancer in Latin American human genomic variants [version 2; peer review: 2 approved]

open access: yesF1000Research, 2018
Background: MicroRNAs are related to human cancers, including cervical cancer (CC) caused by HPV. In 2018, approximately 56.075 cases and 28.252 deaths from this cancer were registered in Latin America and the Caribbean according to GLOBOCAN reports. The
Milena Guerrero Flórez   +3 more
doaj   +1 more source

Deep Learning for Automated Analysis of Cellular and Extracellular Components of the Foreign Body Response in Multiphoton Microscopy Images

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
The Foreign body response (FBR) is a major unresolved challenge that compromises medical implant integration and function by inflammation and fibrotic encapsulation.
Mattia Sarti   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy